India approves pandemic vaccineThe pharmaceutical company Zydus Cadila announced today it has gained approval from the drug controller general of India to become the first India-based firm to market a pandemic H1N1 vaccine in the country. The vaccine, VaxiFlu-S, will be marketed by Vaxxicare, part of a division of the company that focuses on preventives.
(CIDRAP News) An influenza expert who formerly headed the World Health Organization's (WHO's) flu program and now works for Novartis has suggested developing a prepandemic vaccine to get the jump on the next flu pandemican idea that other experts are greeting with caution or skepticism.
Pandemic vaccine sales totaled $3.4 billion
May 10, 2010
(CIDRAP News) A preliminary study from Germany suggests that an adjuvanted vaccine against the pandemic H1N1 virus was highly effective in adolescents and younger adults and moderately effective in older people, according to a report published yesterday in Eurosurveillance.
May 7, 2010
May 6, 2010
Activity on US campuses falls further
